from

UK firms move from AI experimentation to measurable results as the Project Economy matures

Nearly half of UK organisations report productivity or cost improvements from AI, with a growing cohort (12%) already achieving significant…

2 months ago

Statement from OCI Global

AMSTERDAM, April 17, 2026 /PRNewswire/ -- OCI Global N.V. ("OCI" or the "Company") (Euronext: OCI) today released the following statement…

2 months ago

Xinhua Silk Road: Ningbo and China’s shift from making things to making them smarter

BEIJING, April 17, 2026 /PRNewswire/ -- Along China's eastern seaboard, the Ningbo-Zhoushan Port in Zhejiang Province is barely ever quiet. Ships…

2 months ago

Sigenergy Successfully Listed on HKEX with Strong Backing from Top-Tier Global Investors

HONG KONG, April 16, 2026 /PRNewswire/ -- Sigenergy Technology Co., Ltd. ("Sigenergy", Stock Code: 06656.HK) today successfully listed on the…

2 months ago

Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026

SAN DIEGO and NEW YORK, April 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine,…

2 months ago

Risen Energy Secures 1.2GW HJT Module Order from China Huaneng Group, Demonstrating Industry Leadership

NINGBO, China, April 15, 2026 /PRNewswire/ -- Recently, Risen Energy achieved a milestone in its strategic cooperation with China Huaneng Group.…

2 months ago

A Look at the Highlights from Phase 1 of the 139th Canton Fair

GUANGZHOU, China, April 14, 2026 /PRNewswire/ -- Focusing on Advanced Manufacturing, Phase 1 of the 139th Canton Fair is set to…

2 months ago

Breaking the Bottleneck in Medical Imaging Core Components: VITAL MedTech Unveils Its Vertical Integration Solution from Materials to Medical Systems at CMEF 2026

SHANGHAI, April 13, 2026 /PRNewswire/ -- At CMEF 2026, VITAL MedTech, the healthcare unit of VITAL MATERIALS, unveiled a full…

2 months ago

Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy – CORRECTION

April 10, 2026 16:09 ET  | Source: Mesoblast Limited Working with Parent Project Muscular Dystrophy and the Duchenne Registry on…

2 months ago

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

April 10, 2026 17:02 ET  | Source: Replimune, Inc. WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc.…

2 months ago